taxonomy (1)
protein (1)
source (5)
structure (29)
composition (20)
disease (3)
reference (7)
site (3)
peptide (0)
- Homo sapiens (Human)
Taxonomy
- Ascitic fluid (UBERON_0007795)
- Blood Serum (UBERON_0001977)
- Liver (UBERON_0002107) Hep-G2 (CVCL_0027)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Yolk Sac (UBERON_0001040)
Source
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Neu?c(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Neu?c(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)[Fuc(a1-?)]GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
Reported structure
- Hex:3 HexNAc:4 (avg mass : 1317.2225 )
- Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
- Hex:4 HexNAc:2 dHex:1 (avg mass : 1219.1179 )
- Hex:4 HexNAc:4 (avg mass : 1479.3649 )
- Hex:4 HexNAc:4 NeuAc:1 (avg mass : 1770.6228 )
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 1916.7658 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 (avg mass : 2516.3091 )
- Hex:5 HexNAc:5 (avg mass : 1844.7023 )
- Hex:5 HexNAc:5 dHex:1 (avg mass : 1990.8453 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2282.1032 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2573.3611 )
- Hex:6 HexNAc:5 (avg mass : 2006.8447 )
- Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
Composition
- Carcinoma, Gallbladder which metastasises to the liver (DOID:4948)
- Carcinoma, Hepatocellular (DOID:684)
- Tumor, Endodermal Sinus (DOID:1911)
Disease
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Human alpha-fetoprotein produced from Hep G2 cell line: structure and heterogeneity of the oligosaccharide moiety. (1995 - Ferranti P, Pucci P, Marino G, Fiume I, Terrana B, Ceccarini C, Malorni A) / Status : Reviewed
- Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas. (1993 - Yamashita K, Taketa K, Nishi S, Fukushima K, Ohkura T) / Status : Reviewed
- Characterization of E-PHA-reactive alpha-fetoprotein isoforms by two-dimensional lectin affinity electrophoresis. (1993 - Taketa K, Fujii Y, Taga H) / Status : Reviewed
- Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. (1993 - Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H) / Status : Reviewed
- Unique structure of glycopeptide from alpha-fetoprotein produced in human hepatoma cell line, as determined by 1H-nuclear magnetic resonance spectroscopy. (1990 - Terrana B, Tecce M, Manetti R, Ceccarini C, Lamba D, Segre A) / Status : Reviewed
- Sugar chain of alpha-fetoprotein produced in human yolk sac tumor. (1983 - Yamashita K, Hitoi A, Tsuchida Y, Nishi S, Kobata A) / Status : Reviewed
Reference
- Alpha-fetoprotein / Homo sapiens
Reported glycosite
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 1317.2225)
- Blood Serum (UBERON_0001977)
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1463.3655)
- Blood Serum (UBERON_0001977)
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1479.3649)
- Blood Serum (UBERON_0001977)
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1479.3649)
- Blood Serum (UBERON_0001977)
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1625.5079)
- Blood Serum (UBERON_0001977)
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1625.5079)
- Blood Serum (UBERON_0001977)
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1641.5073)
- Carcinoma, Gallbladder which metastasises to the liver (DOID:4948)
- Carcinoma, Hepatocellular (DOID:684)
- Characterization of E-PHA-reactive alpha-fetoprotein isoforms by two-dimensional lectin affinity electrophoresis. (1993 - Taketa K, Fujii Y, Taga H) / Status : Reviewed
- Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. (1993 - Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H) / Status : Reviewed
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
- Asn-251
-
- N-Linked / Complex
(avg mass : 1770.6228)
- Blood Serum (UBERON_0001977)
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1770.6228)
- Blood Serum (UBERON_0001977)
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1787.6503)
- Carcinoma, Gallbladder which metastasises to the liver (DOID:4948)
- Carcinoma, Hepatocellular (DOID:684)
- Characterization of E-PHA-reactive alpha-fetoprotein isoforms by two-dimensional lectin affinity electrophoresis. (1993 - Taketa K, Fujii Y, Taga H) / Status : Reviewed
- Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. (1993 - Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H) / Status : Reviewed
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
- Asn-251
-
- N-Linked / Complex
(avg mass : 1844.7023)
- Carcinoma, Gallbladder which metastasises to the liver (DOID:4948)
- Carcinoma, Hepatocellular (DOID:684)
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1916.7658)
- Blood Serum (UBERON_0001977)
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1916.7658)
- Blood Serum (UBERON_0001977)
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1932.7652)
- Blood Serum (UBERON_0001977)
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1932.7652)
- Blood Serum (UBERON_0001977)
- Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas. (1993 - Yamashita K, Taketa K, Nishi S, Fukushima K, Ohkura T) / Status : Reviewed
- Characterization of E-PHA-reactive alpha-fetoprotein isoforms by two-dimensional lectin affinity electrophoresis. (1993 - Taketa K, Fujii Y, Taga H) / Status : Reviewed
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1932.7652)
- Blood Serum (UBERON_0001977)
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1990.8453)
- Carcinoma, Gallbladder which metastasises to the liver (DOID:4948)
- Carcinoma, Hepatocellular (DOID:684)
- Tumor, Endodermal Sinus (DOID:1911)
- Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. (1993 - Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H) / Status : Reviewed
- Sugar chain of alpha-fetoprotein produced in human yolk sac tumor. (1983 - Yamashita K, Hitoi A, Tsuchida Y, Nishi S, Kobata A) / Status : Reviewed
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
- Asn-251
-
- N-Linked / Complex
(avg mass : 2006.8447)
- Carcinoma, Gallbladder which metastasises to the liver (DOID:4948)
- Carcinoma, Hepatocellular (DOID:684)
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2078.9082)
- Blood Serum (UBERON_0001977)
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2078.9082)
- Blood Serum (UBERON_0001977)
- Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas. (1993 - Yamashita K, Taketa K, Nishi S, Fukushima K, Ohkura T) / Status : Reviewed
- Characterization of E-PHA-reactive alpha-fetoprotein isoforms by two-dimensional lectin affinity electrophoresis. (1993 - Taketa K, Fujii Y, Taga H) / Status : Reviewed
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2078.9082)
- Blood Serum (UBERON_0001977)
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2152.9877)
- Carcinoma, Gallbladder which metastasises to the liver (DOID:4948)
- Carcinoma, Hepatocellular (DOID:684)
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2224.0231)
- Blood Serum (UBERON_0001977)
- Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas. (1993 - Yamashita K, Taketa K, Nishi S, Fukushima K, Ohkura T) / Status : Reviewed
- Characterization of E-PHA-reactive alpha-fetoprotein isoforms by two-dimensional lectin affinity electrophoresis. (1993 - Taketa K, Fujii Y, Taga H) / Status : Reviewed
- Alpha-fetoprotein / Homo sapiens
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2224.0231)
- Carcinoma, Hepatocellular (DOID:684)
- Human alpha-fetoprotein produced from Hep G2 cell line: structure and heterogeneity of the oligosaccharide moiety. (1995 - Ferranti P, Pucci P, Marino G, Fiume I, Terrana B, Ceccarini C, Malorni A) / Status : Reviewed
- Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas. (1993 - Yamashita K, Taketa K, Nishi S, Fukushima K, Ohkura T) / Status : Reviewed
- Characterization of E-PHA-reactive alpha-fetoprotein isoforms by two-dimensional lectin affinity electrophoresis. (1993 - Taketa K, Fujii Y, Taga H) / Status : Reviewed
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
- Asn-251
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2282.1032)
- Yolk Sac (UBERON_0001040)
- Tumor, Endodermal Sinus (DOID:1911)
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2370.1661)
- Carcinoma, Hepatocellular (DOID:684)
- Human alpha-fetoprotein produced from Hep G2 cell line: structure and heterogeneity of the oligosaccharide moiety. (1995 - Ferranti P, Pucci P, Marino G, Fiume I, Terrana B, Ceccarini C, Malorni A) / Status : Reviewed
- Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas. (1993 - Yamashita K, Taketa K, Nishi S, Fukushima K, Ohkura T) / Status : Reviewed
- Characterization of E-PHA-reactive alpha-fetoprotein isoforms by two-dimensional lectin affinity electrophoresis. (1993 - Taketa K, Fujii Y, Taga H) / Status : Reviewed
- Unique structure of glycopeptide from alpha-fetoprotein produced in human hepatoma cell line, as determined by 1H-nuclear magnetic resonance spectroscopy. (1990 - Terrana B, Tecce M, Manetti R, Ceccarini C, Lamba D, Segre A) / Status : Reviewed
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
- Asn-251
-
- N-Linked / Complex
(avg mass : 2370.1661)
- Blood Serum (UBERON_0001977)
- Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas. (1993 - Yamashita K, Taketa K, Nishi S, Fukushima K, Ohkura T) / Status : Reviewed
- Characterization of E-PHA-reactive alpha-fetoprotein isoforms by two-dimensional lectin affinity electrophoresis. (1993 - Taketa K, Fujii Y, Taga H) / Status : Reviewed
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2516.3091)
- Liver (UBERON_0002107) Hep-G2 (CVCL_0027)
- Carcinoma, Hepatocellular (DOID:684)
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2573.3611)
- Yolk Sac (UBERON_0001040)
- Tumor, Endodermal Sinus (DOID:1911)
- Alpha-fetoprotein / Homo sapiens
-
- Hex:4 HexNAc:2 dHex:1 / N-Linked
(avg mass : 1219.1179)
- Alpha-fetoprotein / Homo sapiens
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked
(avg mass : 2224.0231)
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Alpha-fetoprotein / Homo sapiens
Suggested structure
Reported glycosite
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked
(avg mass : 2224.0231)
Suggested structure
Reported glycosite
- Hex:4 HexNAc:2 dHex:1 / N-Linked
(avg mass : 1219.1179)
Source
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2573.3611)
Source
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2516.3091)
Source
Reference
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2370.1661)
Disease
Reference
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2370.1661)
Source
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2282.1032)
Disease
Reference
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2224.0231)
Source
Reference
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2224.0231)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2152.9877)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2078.9082)
Source
Reference
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2078.9082)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2078.9082)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2006.8447)
Disease
Reference
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1990.8453)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1932.7652)
Source
Reference
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1932.7652)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1932.7652)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1916.7658)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1916.7658)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1844.7023)
Disease
Reference
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1787.6503)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1770.6228)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1770.6228)
Disease
Reference
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1641.5073)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1625.5079)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1625.5079)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1479.3649)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1479.3649)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1463.3655)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1317.2225)
